Business Description
Microba Life Sciences Ltd
ISIN : AU0000209868
Description
Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome and engages in providing gut microbiome testing services globally to consumers, clinicians, and researchers. It is also involved in developing new pathology services, therapeutics, and diagnostics based on the human gut microbiome. The company's operating segments are: Testing Services and Supplements, which derive key revenue, and Research and Development. Geographically, the company derives maximum revenue from Australia and the rest from Europe, New Zealand, the United States, Asia, and other regions.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 4.44 | |||||
Equity-to-Asset | 0.7 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | -0.17 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -1.71 | |||||
Beneish M-Score | -3.87 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 20.5 | |||||
3-Year EBITDA Growth Rate | 18.2 | |||||
3-Year EPS without NRI Growth Rate | 12.3 | |||||
3-Year FCF Growth Rate | 14.1 | |||||
3-Year Book Growth Rate | -18.2 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 25.81 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 25.62 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 28.2 | |||||
9-Day RSI | 27.1 | |||||
14-Day RSI | 26.1 | |||||
3-1 Month Momentum % | -6.85 | |||||
6-1 Month Momentum % | -10.53 | |||||
12-1 Month Momentum % | -22.73 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.73 | |||||
Quick Ratio | 1.51 | |||||
Cash Ratio | 1.2 | |||||
Days Inventory | 94.11 | |||||
Days Sales Outstanding | 44.65 | |||||
Days Payable | 176.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -21 | |||||
Shareholder Yield % | -30.81 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 46.77 | |||||
Operating Margin % | -164.42 | |||||
Net Margin % | -132.53 | |||||
EBITDA Margin % | -103.34 | |||||
FCF Margin % | -124.46 | |||||
OCF Margin % | -100.89 | |||||
ROE % | -60.25 | |||||
ROA % | -41.86 | |||||
ROIC % | -73.32 | |||||
3-Year ROIIC % | -30.19 | |||||
ROC (Joel Greenblatt) % | -508.75 | |||||
ROCE % | -53.36 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1.3 | |||||
PB Ratio | 0.76 | |||||
EV-to-EBIT | -0.86 | |||||
EV-to-EBITDA | -1.11 | |||||
EV-to-Revenue | 1.15 | |||||
EV-to-Forward-Revenue | 2.57 | |||||
EV-to-FCF | -1 | |||||
Price-to-GF-Value | 0.15 | |||||
Earnings Yield (Greenblatt) % | -115.06 | |||||
FCF Yield % | -71.62 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Microba Life Sciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 8.435 | ||
| EPS (TTM) (€) | -0.022 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 26.1 | ||
| 14-Day ATR (€) | 0.000951 | ||
| 20-Day SMA (€) | 0.01995 | ||
| 12-1 Month Momentum % | -22.73 | ||
| 52-Week Range (€) | 0.0175 - 0.0538 | ||
| Shares Outstanding (Mil) | 700.31 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Microba Life Sciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Microba Life Sciences Ltd Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Microba Life Sciences Ltd Frequently Asked Questions
What is Microba Life Sciences Ltd(FRA:F3Y)'s stock price today?
The current price of FRA:F3Y is €0.02. The 52 week high of FRA:F3Y is €0.05 and 52 week low is €0.02.
When is next earnings date of Microba Life Sciences Ltd(FRA:F3Y)?
The next earnings date of Microba Life Sciences Ltd(FRA:F3Y) is .
Does Microba Life Sciences Ltd(FRA:F3Y) pay dividends? If so, how much?
Microba Life Sciences Ltd(FRA:F3Y) does not pay dividend.
Press Release
Articles on Microba Life Sciences Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers